Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Psychiatry ; 19(10): 1095-105, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24732670

ABSTRACT

Circulating triglycerides (TGs) normally increase after a meal but are altered in pathophysiological conditions, such as obesity. Although TG metabolism in the brain remains poorly understood, several brain structures express enzymes that process TG-enriched particles, including mesolimbic structures. For this reason, and because consumption of high-fat diet alters dopamine signaling, we tested the hypothesis that TG might directly target mesolimbic reward circuits to control reward-seeking behaviors. We found that the delivery of small amounts of TG to the brain through the carotid artery rapidly reduced both spontaneous and amphetamine-induced locomotion, abolished preference for palatable food and reduced the motivation to engage in food-seeking behavior. Conversely, targeted disruption of the TG-hydrolyzing enzyme lipoprotein lipase specifically in the nucleus accumbens increased palatable food preference and food-seeking behavior. Finally, prolonged TG perfusion resulted in a return to normal palatable food preference despite continued locomotor suppression, suggesting that adaptive mechanisms occur. These findings reveal new mechanisms by which dietary fat may alter mesolimbic circuit function and reward seeking.


Subject(s)
Brain/metabolism , Feeding Behavior/physiology , Motivation/physiology , Reward , Triglycerides/blood , Amphetamine/pharmacology , Animals , Carotid Arteries/metabolism , Central Nervous System Stimulants/pharmacology , Lipoprotein Lipase/metabolism , Male , Mice, Inbred C57BL , Motor Activity/drug effects , Motor Activity/physiology
2.
Diabetes Metab ; 40(3): 191-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24332017

ABSTRACT

Energy homoeostasis is maintained through a complex interplay of nutrient intake and energy expenditure. The central nervous system is an essential component of this regulation, as it integrates circulating signals of hunger and satiety to develop adaptive responses at the behavioural and metabolic levels, while the hypothalamus is regarded as a particularly crucial structure in the brain in terms of energy homoeostasis. The arcuate nucleus (ARC) of the hypothalamus contains at least two intermingled neuronal populations: the neurons that produce neuropeptide Y (NPY); and the Agouti-related protein (AgRP) produced by AgRP/NPY neurons situated below the third ventricle in close proximity to proopiomelanocortin (POMC)-producing neurons. POMC neurons exert their catabolic and anorectic actions by releasing α-melanocyte-stimulating hormone (α-MSH), while AgRP neurons oppose this action by exerting tonic GABAergic inhibition of POMC neurons and releasing the melanocortin receptor inverse agonist AgRP. The release of neurotransmitters and neuropeptides by second-order AgRP neurons appears to take place on a multiple time scale, thereby allowing neuromodulation of preganglionic neuronal activity and subsequent control of nutrient partitioning - in other words, the coordinated regulation of conversion, storage and utilization of carbohydrates vs. lipids. This suggests that the function of AgRP neurons extends beyond the strict regulation of feeding to the regulation of efferent organ activity, such that AgRP neurons may now be viewed as an important bridge between central detection of nutrient availability and peripheral nutrient partitioning, thus providing a mechanistic link between obesity and obesity-related disorders.


Subject(s)
Agouti-Related Protein/metabolism , Arcuate Nucleus of Hypothalamus/metabolism , Metabolic Syndrome/metabolism , Neuropeptide Y/metabolism , Obesity/metabolism , Pro-Opiomelanocortin/metabolism , alpha-MSH/metabolism , Energy Intake , Energy Metabolism , Homeostasis , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Lipid Metabolism , Metabolic Syndrome/etiology , Metabolic Syndrome/physiopathology , Neuropeptides/metabolism , Obesity/complications , Obesity/physiopathology , Weight Gain
SELECTION OF CITATIONS
SEARCH DETAIL
...